Drug discovery

London skyline
#Drug discovery #Events #Turning Science into Business Symposium

Keynote speakers announced for DDW Symposium

On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London. Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they… Read More

#News

#Cancer research #Drug discovery #Leukaemia

CAR-T therapy could be effective cancer treatment, study suggests

CAR-T therapy could be an effective treatment for leukaemia, preclinical data published by biotechnology company Gyala Therapeutics suggests.  The data emerged from a study highlighting the use of CAR-T therapy, GYA01, to treat acute myeloid leukaemia (AML) and T-cell acute lymphoblastic leukaemia (T-ALL). The study is the… Read More

#Cancer Research #News

Vaccine
#Clinical trials #Drug discovery #Immunology / Virology & Vaccines #Vaccines

Human challenge trial for pneumococcal vaccine launches in Malawi  

The first clinical trials for a new vaccine targeting pneumococcal disease in people in Malawi have been launched.  The human challenge trial will enrol 400 people in Malawi making it the biggest trial the country has seen to date.   The launch of the trial comes… Read More

#News

#Cell and gene therapy #Drug discovery #Mental health #National Institute for Health and Care Excellence (NICE)

This week in drug discovery 8-12 September

News round-up for 8-12 September by DDW Editor Reece Armstrong. Fast-track designations by the FDA, clinical trials to advance mental health and pharma team-ups to bring innovations to market are just some of the stories in this week’s news round-up. The top stories FDA fast-tracks Sanofi’s AMD gene therapy… Read More

#News

AI brain partnership
#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Molecular research

How AI drug discovery is reshaping biopharma 

Dr. Sneha Kumar, Charles River’s Strategic Commercial Lead of Logica, explores the extent of what AI can do in the lab and how drug discovery happens if the technology is integrated at every step.   The urgency of a new approach  The numbers tell a story of stubborn inefficiency: Despite decades… Read More

#Exclusive Content

#Biopharma #Drug discovery #Life sciences #Start-ups

Pioneer and AbbVie team up on a Golden Ticket to accelerate human health 

Pioneer Group, a specialist in life science infrastructure and venture building, has again teamed up with biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and hepatology. Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Multiomics #Partnership

MoU signed to advance precision medicine growth in Serbia 

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (BIO4), the Republic of Serbia’s flagship biotechnology and life sciences hub, have announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.  BIO4… Read More

#Business & Investment #News

London skyline
#CRISPR #CRISPR screening #Drug discovery #Genomics #Oncology

Registration open for DDW Symposium in London 

Registration is now open for the DDW Turning Science into Business Symposium. It will take place at the Francis Crick Institute in London on 4 November 2025.   Register here for tickets.  The half day event boasts a stellar line up… Read More

#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Transforming drug discovery with AI and digital labs: Last chance to register

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

Robot holds up a pill
#AI #AI / data analytics / healthtech / informatics #Drug discovery #Generative AI

From knowledge to creation: keeping up with AI 

Generative AI is now rapidly disrupting entire industries and new technology breakthroughs are emerging at pace. As new iterations push the boundaries of deep research and insight generation, the implications for life sciences are both profound and uncertain. Reflecting on the rapid progression of GenAI, and its potential to propel… Read More

#Exclusive Content

Cancer research lab
#Cancer research #Drug development #Drug discovery #Oncology

UK immigration system is a barrier to cancer research, says CRUK 

A new report from Cancer Research UK (CRUK) indicates that the UK immigration system is having a detrimental effect on research in the UK.  CRUK’s institutes are led by and made up of a combination of UK and international researchers, but now it says that the UK… Read More

#News

#Clinical trials #Drug discovery #Funding #Immunology / Virology & Vaccines #Obesity

This week in drug discovery 1-5 September

News round-up for 1-5 September by DDW Editor Reece Armstrong. There have been a number of stories this week promoting promising science in the areas of obesity and cardiology, along with a partnership to advance vaccine science. The top stories Research programme represents a “new frontier in vaccine… Read More

#News

#Advanced Therapies #Drug discovery #Multiomics

White Paper – Accelerating Pharma Innovation and Drug Discovery with 5D Multiomics

Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimise costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data. AVITI24™ 5D multiomics platform offers a new path by capturing RNA,… Read More

#Whitepapers